NASDAQ : ANDA
$0.3 (3.37%)
| Source | Headline |
|---|---|
|
Lupin and Natco Receive Approval from U.S. FDA for Eribulin Mesylate Injection
Lupin and Natco Receive Approval from U.S. FDA for Eribulin Mesylate Injection PR Newswire MUMBAI, India and NAP gurufocus.com - 2026-06-03 04:00:00 |